19 | ipragliflozinIBA
11/2021
-
01/2012 |
18 | Glucose (Dextrose)FDA LinkGeneric
02/2020
-
12/2008 |
12 | Hypoglycemic Agents (Hypoglycemics)IBA
11/2021
-
07/2008 |
10 | Sodium-Glucose Transport ProteinsIBA
06/2021
-
01/2012 |
9 | Sodium-Glucose Transporter 2 InhibitorsIBA
06/2021
-
03/2016 |
9 | Vasopressins (Vasopressin)IBA
01/2012
-
08/2002 |
6 | Streptozocin (Streptozotocin)FDA Link
07/2014
-
12/2008 |
6 | 4- fluoro- 1- (((4- methyl- 1- (methylsulfonyl)piperidin- 4- yl)amino)acetyl)pyrrolidine- 2- carbonitrileIBA
11/2009
-
05/2008 |
5 | Blood Glucose (Blood Sugar)IBA
11/2021
-
02/2009 |
5 | Niacinamide (Nicotinamide)FDA LinkGeneric
09/2013
-
12/2008 |
4 | Insulin (Novolin)FDA Link
09/2013
-
12/2008 |
3 | Therapeutic UsesIBA
01/2020
-
09/2013 |
3 | Proteins (Proteins, Gene)FDA Link
10/2014
-
09/2002 |
3 | Collagen Type IV (Type IV Collagen)IBA
01/2012
-
02/2008 |
3 | Dipeptidyl-Peptidase IV InhibitorsIBA
03/2009
-
07/2008 |
3 | 4'- (4,4- difluoro- 5- (2- oxo- 2- (4- piperidinopiperidino)ethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- methyl- 3- furanilideIBA
06/2007
-
01/2006 |
2 | Pioglitazone (Actos)FDA Link
06/2021
-
11/2019 |
2 | CreatinineIBA
01/2020
-
07/2018 |
2 | AS2444697IBA
01/2020
-
10/2014 |
2 | Hormones (Hormone)IBA
09/2018
-
04/2011 |
2 | dapagliflozinIBA
08/2017
-
07/2016 |
2 | Messenger RNA (mRNA)IBA
10/2014
-
01/2012 |
2 | Fibronectins (Fibronectin)IBA
01/2012
-
05/2008 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011
-
03/2011 |
2 | EnzymesIBA
05/2008
-
04/2008 |
2 | ImmunosorbentsIBA
05/2008
-
04/2008 |
2 | N- (6- methoxy- 5- (2- methoxyphenoxy)- 2- (pyrimidin- 2- yl)pyrimidin- 4- yl)- 2- phenylethenesulfonamide (YM598)IBA
06/2007
-
11/2004 |
2 | conivaptan (Vaprisol)FDA Link
11/2002
-
08/2002 |
2 | 4'- (4,4- difluoro- 5- (2- (4- dimethylaminopiperidino)- 2- oxoethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- phenylbenzanilideIBA
10/2002
-
09/2002 |
1 | Estradiol (Delestrogen)FDA LinkGeneric
08/2021 |
1 | fezolinetantIBA
08/2021 |
1 | Luteinizing Hormone (Lutropin)FDA LinkGeneric
08/2021 |
1 | Follicle Stimulating Hormone (Follitropin)FDA Link
08/2021 |
1 | ThiazolidinedionesIBA
06/2021 |
1 | Metformin (Glucophage)FDA LinkGeneric
02/2020 |
1 | Interleukin-1 Receptor-Associated KinasesIBA
01/2020 |
1 | Hexosaminidases (Hexosaminidase)IBA
01/2020 |
1 | nephrinIBA
01/2020 |
1 | GhrelinIBA
09/2018 |
1 | Neuropeptide YIBA
09/2018 |
1 | CarbohydratesIBA
03/2018 |
1 | Dietary Carbohydrates (Carbohydrate, Dietary)IBA
03/2018 |
1 | 6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
08/2017 |
1 | 1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
08/2017 |
1 | empagliflozinIBA
08/2017 |
1 | CanagliflozinIBA
08/2017 |
1 | SodiumIBA
01/2015 |
1 | CytokinesIBA
10/2014 |
1 | C-Reactive ProteinIBA
10/2014 |
1 | Becaplermin (PDGF-BB)FDA Link
01/2012 |
1 | ThymidineIBA
01/2012 |
1 | Collagen Type I (Type I Collagen)IBA
01/2012 |
1 | Plasminogen Activator Inhibitor 1IBA
01/2012 |
1 | Connective Tissue Growth FactorIBA
01/2012 |
1 | pirfenidoneIBA
01/2012 |
1 | Plasminogen InactivatorsIBA
01/2012 |
1 | Leucine (L-Leucine)FDA Link
01/2012 |
1 | Rosiglitazone (Avandia)FDA Link
03/2011 |
1 | Sitagliptin Phosphate (Januvia)FDA Link
03/2011 |
1 | Gliclazide (Diamicron)IBA
11/2009 |
1 | Hemoglobin AIBA
02/2009 |
1 | Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2009 |
1 | LipidsIBA
02/2009 |
1 | Triglycerides (Triacylglycerol)IBA
02/2009 |
1 | Fatty Acids (Saturated Fatty Acids)IBA
02/2009 |
1 | CholesterolIBA
02/2009 |
1 | Glucagon-Like Peptide 1 (GLP 1)IBA
01/2009 |
1 | Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
01/2009 |